The Lundquist Institute and its start-up company Vitalex Biosciences Announces Strategic Advancement of Second-Generation fungal Vaccine VXV-01 through Phase 1 Trials under $40 Million Competitive Contract from NIH/NIAID - EurekAlert!
The Lundquist Institute awarded $9 million to launch Community Center of Excellence for Regenerative Medicine - EurekAlert!
The Lundquist Institute wins multi-year NIH grant exceeding $11 million to transform diagnosis and treatment of deadly mucormycosis - EurekAlert!
New research from The Lundquist Institute finds ketogenic diet-induced high cholesterol does not predict heart disease - EurekAlert!
The Lundquist Institute announces updates to its Board of Directors - EurekAlert
The Lundquist Institute receives $2.6 million grant from U.S. Army Medical Research Acquisition Activity to develop ... - EurekAlert
